Julie Gardener
New Member
CB2 Receptors In Reproduction
M Maccarrone1,2*1Department of Biomedical Sciences, University of Teramo, Teramo, Italy
2European Center for Brain Research (CERC)/Santa Lucia Foundation, Rome, Italy
*Author for correspondence: Email: mmaccarrone@unite.it
Received June 7, 2007; Revised July 10, 2007; Accepted August 7, 2007.
This article has been cited by other articles in PMC.
Br J Pharmacol. 2008 January; 153(2): 189—198.
Published online 2007 September 10. doi: 10.1038/sj.bjp.0707444
PMCID: PMC2219526
Copyright 2008, Nature Publishing Group
Abstract
Cannabinoids have been always identified as harmful drugs because of their negative effects on male and female reproduction. The discovery of the 'endocannabinoid system (ECS)', composed of bioactive lipids (endocannabinoids), their receptors and their metabolic enzymes, and the generation of mouse models missing cannabinoid receptors or other elements of the ECS, has enabled a wealth of information on the significance of endocannabinoid signalling in multiple reproductive events: Sertoli cell survival, spermatogenesis, placentation, fertilization, preimplantation embryo development, implantation and postimplantation embryonic growth. These studies have also opened new perspectives in clinical applications, pointing to the ECS as a new target for correcting infertility and for improving reproductive health in humans. This review will focus on the involvement of type-2 cannabinoid (CB2) receptors in reproductive biology, covering both the male and female sides. It will also discuss the potential relevance of the immunological activity of CB2 at the maternal/foetal interface, as well as the distinctiveness of CB2 versus type-1 cannabinoid (CB1) receptors that might be exploited for a receptor subtype-specific regulation of fertility. In this context, the different signalling pathways triggered by CB1 and CB2 (especially those controlling the intracellular tone of nitric oxide), the different activation of CB1 and CB2 by endogenous agonists (like anandamide and 2-arachidonoylglycerol) and the different localization of CB1 and CB2 within membrane subdomains, termed 'lipid rafts', will be discussed. It is hoped that CB2-dependent endocannabinoid signalling might become a useful target for correcting infertility, in both men and women.
(Endo)cannabinoids and mammalian reproduction
Mammalian reproduction starts with the interaction between a male gamete (sperm) and a female gamete (egg), leading to fertilization. The fertilized egg (embryo) produces through several mitotic cell divisions the blastocyst, where an inner cell mass (ICM) is surrounded by a trophoblast (Tr) (Dey et al., 2004). The proper embryo is derived exclusively from the ICM, whereas the placenta and extraembryonic membranes are generated from cells contributed by the Tr. It is extremely difficult to define the identity and timeline of the molecular pathways engaged during human pregnancy, because of experimental difficulties generated in part by ethical restrictions. Thus, experiments on animal models like mice or boars, which share with humans a number of reproductive events, and the availability of genetically engineered mice have provided evidence that a number of lipid mediators serve as important signalling molecules during early pregnancy. Among these lipid messengers, prostaglandins, eicosanoids generated from arachidonic acid by cyclooxygenases and lysophosphatidic acid, a small lipid molecule belonging to the lysophospholipid group, are well-recognized signals in reproductive events (Dey, 2005).
During the last decade, increasing evidence has pointed towards the relevance of endocannabinoids, another group of bioactive lipids including amides and esters of arachidonic acid, in both female and male fertility (Park et al., 2004; Wang et al., 2006a). The endocannabinoids that have been best characterized to date are N-arachidonoylethanolamine (anandamide, AEA) and 2-arachidonoylglycerol (2-AG). Both act as endogenous ligands of cannabinoid (CB) receptors, thus mimicking several actions of the natural Cannabis sativa component Δ9-tetrahydrocannabinol (THC), which accounts for the majority of the reproductive hazards in marijuana users (Hall and Solowij, 1998; Piomelli, 2004). With the characterization of the 'endocannabinoid system (ECS)', which comprises endocannabinoids (AEA, 2-AG and other congeners), their receptors, their metabolic enzymes and yet-putative transporters (Kogan and Mechoulam, 2006; Bari et al., 2006a), and with the generation of knockout mouse models where ECS elements were genetically deleted, a large body of molecular and physiological evidence has been accumulated to demonstrate that (endo)cannabinoid signalling is critical in Sertoli cell survival, spermatogenesis, placentation, fertilization, preimplantation embryo development, implantation and postimplantation embryo growth. Table 1 summarizes some of the effects of THC in human reproduction. For an extensive review on the effects of THC and ECS in human and animal reproduction, see Wang et al. (2006a). Here, the main focus will be on the role of type-2 cannabinoid (CB2) receptors in endocannabinoid signalling implicated in reproductive biology, in both males and females. Also, the distinctiveness of CB2 receptors versus type-1 cannabinoid (CB1) receptors will be discussed, to speculate on the potential relevance of these two different receptor subtypes in regulating fertility. It is hoped that a deeper insight would lead to potential clinical applications of the CB2-dependent endocannabinoid signalling as a target for correcting infertility and improving reproductive health in humans.
Table 1
Effect of Cannabis sativa component THC on human reproductive events
Type-2 cannabinoid receptors in female fertility: animal studies
In mice, both CB1 and CB2 receptor subtypes are expressed in preimplantation embryos, whereas only CB1 is expressed in the oviduct and uterus (Das et al., 1995; Paria et al., 1995, 2001; Wang et al., 2004). CB2 mRNA is present already at the one-cell stage and is maintained through the blastocyst stage; instead, CB1 mRNA is detected only from the four-cell through the blastocyst stage (Paria et al., 1995). The presence of CB1 mRNA and protein in preimplantation embryos correlates well with high-affinity binding sites for [3H]AEA (Yang et al., 1996; Paria et al., 2001), and consistently blastocyst CB1 is biologically active (Das et al., 1995; Paria et al., 1995). Indeed, the development of two-cell embryos into blastocysts can be arrested by the addition of synthetic (CP55940, WIN55212-2), natural (THC) or endogenous (AEA and 2-AG) CBs in culture (Paria et al., 1995; Paria et al., 1998). Moreover, a reduction in trophectodermal cells was noted in those blastocysts that escaped the developmental arrest in the presence of CB agonists (Yang et al., 1996), whereas the addition of selective antagonists of CB1 (SR141716), but not of CB2 (SR144528), reversed these adverse effects (Paria et al., 1998). However, recent observations of CB2 expression in early embryos and embryonic stem cells by microarray analysis (Sharov et al., 2003), and the absence of its expression in Tr stem cells derived from preimplantation blastocysts (Wang et al., 2006a), seem to suggest that CB2 is restricted to the ICM cells. Taken together, these results suggest that (endo)cannabinoids mediate their actions on preimplantation embryos via CB1, whereas the physiopathological relevance of CB2 expression in the early embryo is yet to be defined.
With the availability of CB receptor knockout mice in the late 1990s (Ledent et al., 1999; Zimmer et al., 1999), the physiological relevance of CB signalling during early embryo development has been further examined. Incidentally, CB1 knockouts developed by Zimmer's group and those developed by Ledent's group did not differ in litter size, yet the former mice showed an increased mortality rate between 8 and 24 weeks, although not neonatally (Zimmer et al., 1999). In studies comparing the in vivo developmental potential of CB receptor-mutant embryos with wild-type embryos, asynchronous development was observed in CB1(−/−), CB2(−/−) or CB1(−/−)/CB2(−/−) double-mutant embryos (Paria et al., 2001; Wang et al., 2004). These studies provided genetic evidence that CB2, as well as CB1, is critical for preimplantation embryo development in vivo, and in fact CB2(−/−) embryos show the same asynchronous development as CB1(−/−) or CB1(−/−)/CB2(−/−) double-mutant embryos (Paria et al., 2001). In this context, it should also be recalled that double-knockout mice did give birth to live pups, suggesting that the activity of uterine and embryonic CB receptors in controlling reproduction can be compensated by other yet-unknown mechanisms (Paria et al., 2001). To further ascertain whether embryos deficient in CB receptors respond to endocannabinoids in vitro, two-cell wild-type or mutant embryos were cultured in the presence or absence of AEA. While a comparable development of wild-type and mutant embryos was observed in the absence of AEA, CB1(−/−) and CB1(−/−)/CB2(−/−) mutant embryos, but not CB2(−/−) or wild-type embryos, were resistant to the inhibitory action of AEA (Paria et al., 2001). This observation reinforces the tenet that CB1 is the functional receptor for ensuring normal embryo growth and differentiation to blastocysts, and suggests that a role for CB2 in these processes can be anticipated, but still awaits clarification. For instance, since CB2 is expressed in the embryonic stem cells but not in Tr stem cells (Sharov et al., 2003), it is conceivable that CB2 plays a role in specifying pluripotent ICM cell lineage during blastocyst formation. Moreover, a recent report has shown that the inhibitory effect of THC on Tr cell proliferation and gene transcription is mediated via the CB2 receptor (Taylor et al., 2007), shedding some light on the possible functional meaning of this receptor in reproductive events.
During early pregnancy, another critical event occurring in parallel with embryonic preimplantation development is the embryos' timely transport from the oviduct into the uterus. In mice, embryos at the late morula or early blastocyst stage enter the uterus, where they develop and differentiate to achieve implantation competence, escape from the zona pellucida and implant into the receptive uterus. Thus, normal oviductal embryo transport is one of the prerequisites for on-time initiation of implantation in uterus, whereas a dysfunctional regulation of this process resulting from oviductal embryo retention would increase the incidence of pregnancy failure or cause tubal (ectopic) pregnancy in humans. Elegant studies on oviductal embryo transport in CB1(−/−), CB2(−/−) or CB1(−/−)/CB2(−/−) double-mutant females have conclusively demonstrated that the maternal expression of CB1 in the reproductive tracts plays a fundamental role in ensuring normal oviduct-to-uterus transport of embryos, and its deficiency results in embryo retention in the oviduct for an extended period, and hence in reduced fertility of CB1(−/−) mice. On the other hand, CB2 does not seem to play any role in the control of embryo transport through the oviduct (Wang et al., 2004), whereas a different regional expression of AEA-hydrolase fatty acid amide hydrolase (Maccarrone and Finazzi-Agrò, 2004) and of AEA-synthase N-acylphosphatidylethanolamine—phospholipase D (Guo et al., 2005) does contribute to generate an appropriate level of AEA conducive to preimplantation embryo growth and transportation (Wang et al., 2006b).
Collectively, these observations in mouse models provide evidence that while embryonic CB1 primarily contributes to normal embryo development, oviductal CB1 directs the timely oviductal transport of embryos. They also suggest that a role for CB2 in vivo can be expected in embryo development, and possibly in ICM cell lineage determination.
Type-2 cannabinoid receptor in female fertility: human studies
The expression of CB receptors has been investigated also in human uterus during pregnancy, to ascertain the effects of (endo)cannabinoids on myometrial contractility (Dennedy et al., 2004). Using human biopsy specimens obtained at elective caesarean delivery, AEA and THC were found to exert a direct and equally potent relaxant effect on myometrial contractility in vitro. This relaxant effect was prevented by CB1 antagonist SR141716 but not by CB2 antagonist SR144528, although human endometrium expresses both receptor subtypes (Dennedy et al., 2004). These data highlight a possible role for exogenous and endogenous CBs during human parturition, suggesting that the relaxation component is under control of CB1 only. On the other hand, the implications of CB2 expression in human uterus during pregnancy remain to be elucidated.
Another interesting human study has investigated the presence of ECS in human placenta (Helliwell et al., 2004). Remarkably, no CB1 mRNA was detected by reverse transcriptase PCR in samples (n=14) extracted from first trimester tissues, whereas CB2 mRNA was evident in 10 of the 14 samples (Helliwell et al., 2004). In accordance with these data, no CB1-positive immunoreactivity was identified in placental tissues, whereas CB2-positive labelling was observed within the villous stroma (Helliwell et al., 2004). Interestingly, the CB2-positive cells immunoreacted also to anti-CD14 antibodies, demonstrating that they were villous macrophages. Taken together, these data seem to suggest that human placenta expresses only CB2 receptor, which might be engaged in the placentation process. In addition, it is likely that CB2 receptors are involved in normal immune response during early pregnancy. In line with this, lipopolysaccharide-stimulated macrophages secrete AEA (Liu et al., 2003), suggesting that increased local levels of this endocannabinoid may be one mechanism contributing to poor pregnancy outcome after bacterial infection (Silver et al., 1995; Romero et al., 2002). In addition, AEA blocks the release of leukaemia inhibitory factor (Maccarrone and Finazzi-Agrò, 2004), which is essential for the successful reproduction of all mammals (Piccinni et al., 1998). More in general, it is well known that mammalian reproduction is subjected to tight immunoregulation. In fact, normal gestation is based on an early immunological adaptation that involves peripheral T lymphocytes of pregnant women (Piccinni et al., 1998; Sharkey, 1998; Maccarrone and Finazzi-Agrò, 2004). These cells produce type-1 T-helper (Th1) and type-2 T-helper (Th2) cytokines, which have opposite effects on Tr growth. Th2 cytokines (interleukin (IL)-3, IL-4 and IL-10) favour blastocyst implantation and successful pregnancy by promoting Tr growth either directly or indirectly through the inhibition of natural killer cell activity and the stimulation of natural suppressor cells. Conversely, type-1 T-helper cytokines (IL-2, IL-12 and interferon-γ) impair gestation by causing a direct damage to the Tr, by stimulating natural killer cells and by enhancing secretion of tumour necrosis factor-α by macrophages. The Tr stimulates the release of profertility Th2 cytokines from T lymphocytes (the so-called 'Th2 bias') through IL-4, whereas the antifertility type-1 T-helper cytokines bias is signalled by IL-2. Also, progesterone plays a role in this network, inducing the Th2 bias by binding to a specific receptor in T cells. The resulting hormone—cytokine network is a key element at the maternal/foetal interface, and a defect in its integrity may result in foetal loss (Chaouat et al., 1995; Szekeres-Bartho et al., 1996; Piccinni et al., 1998; Duval et al., 2000). On this background, it seems of major interest that in several experimental paradigms, CB2 has been shown to regulate the release of cytokines relevant for fertility, as summarized in Table 2. Therefore, it is conceivable that CB2 in first trimester placenta might contribute to control the cytokine network responsible for the maternal/foetal cross talk.
Table 2
Immunological actions of CB2 receptors
Type-2 cannabinoid receptor in male fertility: human studies
(Endo)cannabinoid signalling has been proposed to regulate sperm functions required for fertilization in a variety of organisms, spanning from lower invertebrates to higher mammals (Schuel and Burkman, 2005). Evidence that N-acylethanolamines like AEA are present in human reproductive fluids in the low nanomolar range (up to ∼70nM) (Schuel et al., 2002a) and that AEA may regulate human sperm functions (Schuel et al., 2002b) has been recently presented. Additionally, in vitro studies have demonstrated that the AEA congener N-palmitoylethanolamine may affect the time course of capacitation of human sperm, by modulating the properties of their membranes (Ambrosini et al., 2003). In this context, it should be recalled that ejaculated sperm from mammals must undergo a functional maturation to become capable of fertilizing an oocyte. Sperm acquire fertilization competence as they reside in the female genital tract where, after a series of physiological changes, they become 'capacitated', that is able to fertilize the egg (Yanagimachi, 1994). Capacitation consists of changes occurring at two sites: in the head of the sperm, which enable it to bind to the zona pellucida proteins and to undergo the acrosome reaction (AR); and in the flagellum, where hyperactivated sperm motility is facilitated.
Recently, AEA has been shown to reduce human sperm motility (Whan et al., 2004). In addition, by means of reverse transcriptase PCR and immunochemistry, human sperm have been shown to express CB1, whereas CB2 protein could not be detected by western blot analysis (Rossato et al., 2005). CB1 was localized in the head and middle piece of the sperm, and its activation by AEA reduced sperm motility and inhibited capacitation-induced AR. Yet, CB1 activation did not induce any variation in sperm intracellular calcium concentrations, but produced a rapid plasma membrane hyperpolarization that was reduced by the K+ channel blocker tetraethylammonium. Notably, the effects of AEA on human sperm motility were dependent on the reduction of sperm mitochondrial activity as determined by rhodamine 123 fluorescence (Rossato et al., 2005). These data lead to the suggestion that the activity of AEA on human sperm functions requires CB1 activation, yet the presence of functional CB1 receptors in human sperm was not ascertained. Neither the presence of the gene encoding for CB2 receptors, nor the ability of human sperm to bind, synthesize, transport and degrade AEA was demonstrated. On this background, another study has investigated whether sperm cells of boar (Sus scropha) were able to bind and metabolize AEA, and whether this endocannabinoid might modulate sperm functions with a cause—effect relationship.
Type-2 cannabinoid receptor in male fertility: animal studies
It should be recalled that boar closely resembles the physiology of humans (Logan and Sharma, 1999), and thus its sperm are largely used as a model system for experiments on reproductive physiology (Barboni et al., 1995; Mattioli et al. 1996; James et al., 2004).
Boar sperm have been shown to possess the biochemical machinery to bind, synthesize and degrade AEA (Maccarrone et al., 2005). Activation of CB1 by the AEA stable analogue methanandamide inhibits capacitation and hence the ability of sperm cells to react to zona pellucida proteins with acrosome exocytosis, through a cAMP-dependent pathway. Unlike zona pellucida-induced AR, CB1 was ineffective on spontaneous AR (Maccarrone et al., 2005). Moreover, once sperm have completed capacitation, AEA stabilizes the acrosome membranes by activating vanilloid receptors, thus reducing spontaneous AR. Interestingly, boar sperm express also CB2, which represents ∼15% of total CB receptors according to western blot analysis and binding data (Maccarrone et al., 2005). To date, it is not yet clear as to which role could be played by this receptor subtype, but chances are that it contributes, directly or indirectly, to sperm activation. In fact, the data suggest that sperm function is regulated by endocannabinoids through a dual stage-dependent effect. On the one hand, AEA, present in both seminal plasma and uterine fluids, prevents premature capacitation in freshly ejaculated sperm via a CB1 (and potentially CB2)-mediated mechanism; in this way, AEA contributes to maintain a suitable environment for the sperm to travel along the uterine tract without any fertilizing potential, but in a condition of membrane stability. On the other, a few hours later, when sperm have reached the oviduct (a condition that corresponds to the incubation in vitro under capacitating conditions), this inhibitory brake becomes looser. In fact, sperm are exposed to a progressively reduced concentration of AEA in the proximal female genital tract (Schuel et al., 2002a), and sperm capacitation may occur as a consequence of CB1 (and possibly CB2) disinhibition. At this time, intracellular endocannabinoids may become a major switch in the regulation of sperm function, and an increase in endogenous AEA may be necessary to activate vanilloid receptors and prevent spontaneous AR. As a consequence, AR will result only from sperm—egg interactions, thus maximizing the fertilizing potential of the sperm population. It should be stressed that these endocannabinoid-mediated cross talks between sperm and egg need further investigation. At any rate, the observation that sperm cells have a complete ECS adds a new player to hormone/cytokine networks regulating fertility in mammals. In the same line, the presence of a fully functional ECS in sperm supports the hypothesis that endocannabinoid signalling can contribute to block polyspermy, by controlling retrograde AEA activity in much the same way as it happens within the CNS (Schuel and Burkman, 2005). According to this model, AEA released from the egg following activation by their fertilizing sperm binds to CB1 (and possibly CB2) receptors on nearby sperm, to inhibit the AR, thereby preventing the sperm from penetrating the egg prior to completion of the cortical reaction (Schuel and Burkman, 2005).
Also, the function of mouse Sertoli cells has been shown to be altered by THC (Newton et al., 1993), although the molecular basis for this alteration has not been established. As Sertoli cells of the mammalian seminiferous epithelium are involved in the regulation of germ cell development by providing nutrients and hormonal signals needed for spermatogenesis, their ability to bind and degrade AEA may be important in controlling the spermatogenic output. Sertoli cells have the biochemical machinery to bind and degrade AEA, and this machinery was characterized in a cell age range 4—24 days, largely used as a model of immature mice in endocrinological studies (Maccarrone et al., 2003). Immature Sertoli cells express functional CB2 receptors, but not CB1 receptors, on their surface, and the level of these receptors is constant during ageing (Maccarrone et al., 2003). An interesting observation is that AEA can force Sertoli cells to apoptosis, and that this process is more evident upon ageing (Maccarrone et al., 2003). Additionally, CB2 receptors expressed by Sertoli cells have a protective role against the toxic effects of AEA, and so has follicle-stimulating hormone. The latter substance dramatically impacts foetal and early neonatal Sertoli cell proliferation, and it is critical in determining the spermatogenic capacity in the adult mammals (Orth et al., 1998). It can be suggested that altered levels of follicle-stimulating hormone during testis development can control the proapoptotic potential of AEA, thus contributing to the differentiation process (Rossi et al., 2007). This observation, together with the well-established relationship of Sertoli cell number to the total spermatogenic output of the testis, can contribute to the negative effects exerted on testicular development by altered follicle-stimulating hormone concentrations, as well as by mutations of the follicle-stimulating hormone receptor gene (Tapanainen et al., 1997). Taken together, the finding that Sertoli cells partake in the peripheral ECS and that CB2 regulates their survival (and hence the final spermatogenic output), seems to open new perspectives in the understanding and treatment of male infertility.
The overall distribution of CB2 in reproductive organs of both the male and female sides is summarized in Table 3. A major question that remains open is regarding the advantage that might be conferred by CB2, in addition to or in place of CB1, to reproductive performance. Some clues that might help to answer this question are discussed in the following section.
Table 3
Distribution and activity of CB2 receptors in reproductive cells and tissues
Distinctiveness of type-2 cannabinoid versus type-1 cannabinoid receptors
Both CB1 and CB2 receptors belong to the rhodopsin family of G-protein-coupled seven transmembrane spanning receptors. They show 44% overall identity with 68% identity within the transmembrane regions, and are coupled mainly to the Gi/o family of G proteins (Howlett et al., 2002; Howlett et al., 2004). Signal-transduction pathways regulated by both CB receptor subtypes include the inhibition of AC and the activation of mitogen-activated protein kinase and of cytosolic phospholipase A2. However, only CB1 regulates ionic currents (inhibition of voltage-gated L, N and P/Q-type Ca2+ channels, activation of K+ channels), and CB1 activates, whereas CB2 inhibits nitric oxide synthase (Howlett et al., 2004; Demuth and Molleman, 2006).
The opposite effect of CB1 versus CB2 on nitric oxide (NO) release might be relevant for the in vivo control of reproduction, because NO plays several roles in male (Lewis et al., 1996; Donnelly et al., 1997; Herrero et al., 2003) and female fertility (Maul et al., 2003). For instance, NO regulates the contribution of Sertoli cells to fertility and inflammation-mediated infertility (O'Bryan et al., 2000; Fujisawa et al., 2001). In addition, it is produced by sperm and acts as an intracellular signalling molecule in the processes of capacitation and AR. It has been documented that during capacitation, NO interacts with the protein kinase A pathway and is also involved in tyrosine nitration of sperm proteins (Herrero et al., 2001). On the other hand, during progesterone-induced AR, NO stimulates cyclooxygenase activity with a subsequent increase in prostaglandin E2. Furthermore, the ability of NO-releasing compounds to induce AR has been shown to occur via an increase in cGMP levels and subsequent protein kinase G activation. NO is also a major paracrine mediator and an important regulatory agent in various female reproductive processes, such as ovulation, implantation, pregnancy maintenance, labour and delivery (Maul et al., 2003). In ovulation, circulating NO products are increased during follicle development and decreased right after ovulation. In implantation, NO also regulates endometrial functions such as endometrial receptivity, implantation and menstruation, so that NO donors may be useful for promoting fertility, while NO inhibitors might be used for contraception. Moreover, throughout gestation myometrial NO production is upregulated, thus contributing to achieve uterine quiescence; then, close to term NO production decreases, thus promoting effective contractions that result in labour (Maul et al., 2003). Since human endometrium expresses both CB1 and CB2 (Dennedy et al., 2004), it is conceivable that these two receptor subtypes are engaged at different time points to modulate in opposite ways NO content and thus NO-dependent effects. In contrast to the myometrium, NO production in the cervix is low during gestation and becomes upregulated once pregnancy advances to term. The findings from animal studies have been confirmed by several clinical trials, so that it is now believed that NO donors and nitric oxide synthase inhibitors may provide novel, effective, safe and inexpensive drugs to regulate and steer various functions in female reproductive life. Given this, it is tempting to speculate that a spatiotemporal regulation of CB1 versus CB2 expression might be instrumental in enhancing or reducing NO-dependent actions on both sides of mammalian fertility, thus opening a new avenue for CB-oriented therapeutic intervention. On a final note, it should be recalled that CB2-specific signalling pathways may exist, which impact reproductive events in yet-unknown ways.
A second point of interest is that AEA is only a partial agonist of CB2, whereas 2-AG is a full agonist of both CB receptor subtypes (Howlett et al., 2004; Demuth and Molleman, 2006). Therefore, it is conceivable that a differential regulation of 2-AG metabolism, through its synthetic enzyme diacylglycerol lipase (Bisogno et al., 2003) or hydrolytic enzyme monoacylglycerol lipase (Dinh et al., 2002), might serve to modulate CB2 rather than CB1. However, preliminary data on 2-AG metabolism in the uterus of leptin knockout (ob/ob) mice (Maccarrone et al., 2004) that are infertile (Ahima and Flier, 2000), and more recent evidence in the mouse uterus during embryo implantation (Wang et al., 2007), seem to suggest that changes in 2-AG are superimposable on those of AEA. Interestingly, in both studies, 2-AG levels were found to be ∼2 orders of magnitude higher than those of AEA, and this finding raises the question as to why 2-AG, which is detrimental to early embryo development (Wang et al., 2007), is present in the pregnant uterus at such higher levels than AEA. It is possible that a specific, yet-to-be-disclosed activity of 2-AG, possibly mediated through CB2, might be needed for regulating the 'window' of implantation by synchronizing embryo development and blastocyst activation with preparation of the uterus to the receptive state (Wang et al., 2007).
A third point of interest stems from mounting evidence accumulated in the last few years, showing that lipid rafts (LRs) are involved in the trafficking and functioning of CB1 receptors (McFarland and Barker, 2005). LRs are specialized membrane microdomains biochemically defined by the insolubility of their components in cold non-ionic detergents (Simons and Toomre, 2000). They are believed to mediate the regulation of signal transduction through several different mechanisms, for example, by favouring the internalization of specific components of the signalling chain, such as G-protein-coupled receptors and G proteins (Le et al., 2002; Barnett-Norris et al., 2005). LRs disruption by methyl-β-cyclodextrin, a membrane cholesterol depletor, has been shown to double CB1-dependent signalling via AC and mitogen-activated protein kinase in neuronal cells (Bari et al., 2005). In line with this, a recent paper has demonstrated that CB1 is physically associated with LRs in breast cancer cells, suggesting that membrane subdomains might represent a cellular device for its intracellular trafficking, as well as a favourable platform to regulate CB1 signalling (Sarnataro et al., 2006; Oddi et al., 2007). Unlike CB1, CB2 in leukaemic cells is insensitive to raft perturbation, suggesting that this receptor subtype does not localize within LRs (Bari et al., 2006b). The molecular basis of the different sensitivity of CB receptor subtypes to raft integrity might be very complex, and to be clarified it needs a more detailed analysis of the three-dimensional structures of the two receptors and their interactions in the context of the membrane bilayers. However, it should be recalled that the most important differences between CB1 and CB2 are located in the N-terminal extracellular loop II, in the C terminus of transmembrane helix 7 and in the C terminus (Montero et al., 2005). Moreover, a recent study using combined high-resolution nuclear magnetic resonance and computer modelling has shown that CB1 and CB2 have conformational properties and salt bridge differences in the so-called juxtamembrane segment (or helix 8), which is critical for their activity and regulation and, more notably, is under the influence of the surrounding chemical environment (Xie and Chen, 2005). On this basis, it is tempting to speculate that LRs might regulate CB1 receptor by interacting with the specific regions of its three-dimensional structure, such as helix 8 (Xie and Chen, 2005), or helices 3 and 6 (Tian et al., 2005). Interestingly, a role for LRs in reproduction has been recently documented (Noble et al., 2007). For instance, LRs have been recognized as a critical factor in the pathways involved in Ca2+ signalling in the uterus, with an impact on the prevention of preterm and difficult labours (Noble et al., 2007). In fact, the increases in cytosolic Ca2+ and contractility that occur with raft disruption are due, at least in part, to effects on large conductance Ca2+-activated K+ channels, localized within LRs. It is possible that CB1-dependent control of ion conductances may play a role in this mechanism, whereas activation of CB2 might be a means of triggering signal-transduction pathways common to CB1 without alteration of ion currents.
Concluding remarks and future perspectives
A role for the endogenous CB system in several aspects of mammalian reproduction has been proposed, through the activation of CB and vanilloid receptors, and/or via non-receptor-mediated actions. In the case of AEA, the control of its activity on the reproductive system seems to be dependent on its endogenous tone, which in turn depends on fatty acid amide hydrolase. In fact, fatty acid amide hydrolase is under control of well-known regulators of fertility, such as type-1 T-helper/Th2 cytokines, progesterone and leptin, so that this enzyme can be considered a 'guardian angel' (Maccarrone and Finazzi-Agrò, 2004) or a 'gatekeeper' (Wang et al., 2006b) of mammalian reproduction. Fluctuations of endocannabinoid levels during the human ovulatory cycle (Lazzarin et al., 2004) reinforce the tenet that ECS contributes to the regulation of fertility. Also, CB1 receptors play a major role in the effect of endocannabinoids on reproductive events, and it remains to be established which potential advantage could be conferred by the expression of CB2 for improving reproductive performance. Here, we have summarized the distribution of CB2 mRNA and/or protein in reproductive cells and tissues, and have shown that this receptor subtype may be involved in placentation, maternal/foetal signalling, specification of ICM cell lineage and embryo development in vivo (in females), as well as in Sertoli cell survival, spermatogenesis and sperm—oocyte interactions including blockade of polyspermy (in males). Figure 1 summarizes the reproductive events potentially under control of CB2-dependent signalling. Awaiting for new experimental data that may further clarify the impact of CB2 on reproduction, we have also speculated that certain distinctiveness of CB2 versus CB1 may represent an advantage for reproductive performance. In line with this, it is tempting to propose that (i) a differential signal transduction (especially for the pathway that regulates the endogenous tone of NO), (ii) a differential regulation of the metabolism of the CB2 full agonist 2-AG and (iii) a differential sensitivity of CB2 versus CB1 to LRs integrity may represent useful aspects that might favour reproduction in mammals (Figure 2). Overall, it is hoped that a deeper understanding of endocannabinoid signalling, in particular the CB2-dependent branch, might help to correct human infertility, in both men and women.
Figure 1
Potential roles of CB2 receptors in male and female reproductive events. See text for details. CB2, type-2 cannabinoid.
Figure 2
Distinctiveness of CB2 versus CB1 receptors that may be relevant for reproduction. See text for details. CB1, type-1 cannabinoid; CB2, type-2 cannabinoid.
Acknowledgments
I thank Prof Alessandro Finazzi-Agrò (Department of Experimental Medicine and Biochemical Sciences, University of Rome 'Tor Vergata') for his continuing support, and all colleagues who gave their valuable contribution over the years to the fertility studies. My deep gratitude goes also to Dr Natalia Battista (University of Teramo) for her kind help in preparing the artwork. This work was supported by Fondazione TERCAS (Research Program 2004), and by Ministero dell'Università e della Ricerca (COFIN 2006 and FIRB 2006).
Abbreviations
AEA N-arachidonoylethanolamine (anandamide)
2-AG 2-arachidonoylglycerol
AR acrosome reaction
CB1/2 type-1/2 cannabinoid receptor
ECS endocannabinoid system
ERK extracellular signal-regulated kinase
ICM inner cell mass
IL interleukin
IVF in vitro fertilization
LH luteinizing hormone
LR lipid raft
MCP-1 monocyte chemoattractant protein-1
Th1/2 type 1/2 T-helper
THC Δ9-tetrahydrocannabinol
Tr trophoblast
Notes
Conflict of interest
The author states no conflict of interest.
References
Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000;62:413—437. [PubMed]
Ambrosini A, Zolese G, Wozniak M, Genga D, Boscaro M, Mantero F, et al. Idiopathic infertility: susceptibility of spermatozoa to in-vitro capacitation, in the presence and the absence of palmitoylethanolamide (a homologue of anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. Mol Hum Reprod. 2003;9:381—388. [PubMed]
Barboni B, Mattioli M, Seren E. Influence of progesterone on boar sperm capacitation. J Endocrinol. 1995;144:13—18. [PubMed]
Bari M, Battista N, Fezza F, Finazzi-Agrò A, Maccarrone M. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J Biol Chem. 2005;280:12212—12220. [PubMed]
Bari M, Battista N, Fezza F, Gasperi V, Maccarrone M. New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev Med Chem. 2006a;6:257—268. [PubMed]
Bari M, Spagnuolo P, Fezza F, Oddi S, Pasquariello N, Finazzi-Agrò A, et al. Effect of lipid rafts on cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. J Immunol. 2006b;177:4971—4980. [PubMed]
Barnett-Norris J, Lynch D, Reggio PH. Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system. Life Sci. 2005;77:1625—1639. [PubMed]
Bauman J. Health Consequence of Marijuana Use. US Government Printing Office: Washington, DC; 1980. Marijuana and the female reproductive system; pp. 85—97.
Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol. 2003;163:463—468. [PMC free article] [PubMed]
Borner C, Hollt V, Kraus J. Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells. Mol Pharmacol. 2006;69:1486—1491. [PubMed]
Brown SM, Wager-Miller J, Mackie K. Cloning and molecular characterization of the rat CB2 cannabinoid receptor. Biochim Biophys Acta. 2002;1576:255—264. [PubMed]
Chaouat G, Menu E, Delage G, Moreau JF, Khrishnan L, Hui L, et al. Immuno-endocrine interactions in early pregnancy. Hum Reprod. 1995;10:55—59. [PubMed]
Cone EJ, Johnson RE, Moore JD, Roache JD. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol Biochem Behav. 1986;24:1749—1754. [PubMed]
Correa F, Mestre L, Docagne F, Guaza C. Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling. Br J Pharmacol. 2005;145:441—448. [PMC free article] [PubMed]
Das SK, Paria BC, Chakraborty I, Dey SK. Cannabinoid ligand—receptor signaling in the mouse uterus. Proc Natl Acad Sci USA. 1995;92:4332—4336.
Day N, Sambamoorthi U, Taylor P, Richardson G, Robles N, Jhon Y, et al. Prenatal marijuana use and neonatal outcome. Neurotoxicol Teratol. 1991;13:329—334. [PubMed]
Demuth DG, Molleman A. Cannabinoid signaling. Life Sci. 2006;78:549—563. [PubMed]
Dennedy MC, Friel AM, Houlihan DD, Broderick VM, Smith T, Morrison JJ. Cannabinoids and the human uterus during pregnancy. Am J Obstet Gynecol. 2004;190:2—9. [PubMed]
Dey SK. Reproductive biology: fatty link to fertility. Nature. 2005;435:34—35. [PubMed]
Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, et al. Molecular cues to implantation. Endocr Rev. 2004;25:341—373. [PubMed]
Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA. 2002;99:10819—10824.
Donnelly ET, Lewis SE, Thompson W, Chakravarthy U. Sperm nitric oxide and motility: the effects of nitric oxide synthase stimulation and inhibition. Mol Hum Reprod. 1997;3:755—762. [PubMed]
Duval D, Reinhardt B, Kedinger C, Boeuf H. Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF)-dependent embryonic stem cell survival. FASEB J. 2000;14:1577—1584. [PubMed]
Frank DA, Bauchner H, Parker S, Huber AM, Kyei-Aboagye K, Cabral H, et al. Neonatal body proportionality and body composition after in utero exposure to cocaine and marijuana. J Pediatr. 1990;117:622—626. [PubMed]
Fried PA, Watkinson B, Willan A. Marijuana use during pregnancy and decreased length of gestation. Am J Obstet Gynecol. 1984;150:23—27. [PubMed]
Fujisawa M, Yamanaka K, Tanaka H, Okada H, Arakawa S, Kamidono S. Expression of endothelial nitric oxide synthase in the Sertoli cells of men with infertility of various causes. BJU Int. 2001;87:85—88. [PubMed]
Gertsch J, Schoop R, Kuenzle U, Suter A. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett. 2004;577:563—569. [PubMed]
Greenland S, Richwald GA, Honda GD. The effects of marijuana use during pregnancy. II. A study in a low-risk home-delivery population. Drug Alcohol Depend. 1983;11:359—366. [PubMed]
Greenland S, Staisch KJ, Brown N, Gross SJ. Effects of marijuana on human pregnancy, labor and delivery. Neurobehav Toxicol Teratol. 1982;4:447—450. [PubMed]
Guo Y, Wang H, Okamoto Y, Ueda N, Kingsley PJ, Marnett LJ, et al. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J Biol Chem. 2005;280:23429—23432. [PubMed]
Hall W, Solowij N. Adverse effects of cannabis. Lancet. 1998;352:1611—1616. [PubMed]
Harmon J, Aliapoulios MA. Gynecomastia in marihuana users. N Engl J Med. 1972;287:936.
Hatch EE, Bracken MB. Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol. 1986;124:986—993. [PubMed]
Helliwell RJ, Chamley LW, Blake-Palmer K, Mitchell MD, Wu J, Kearn CS, et al. Characterization of the endocannabinoid system in early human pregnancy. J Clin Endocrinol Metab. 2004;89:5168—5174. [PubMed]
Hembree WC, Nahas GG, Zeidenberg P, Huang HF. Changes in human spermatozoa associated with high dose marihuana smoking. Adv Biosci. 1978;23:429—439.
Herrero MB, de Lamirande E, Gagnon C. Tyrosine nitration in human spermatozoa: a physiological function of peroxynitrite, the reaction product of nitric oxide and superoxide. Mol Hum Reprod. 2001;7:913—921. [PubMed]
Herrero MB, de Lamirande E, Gagnon C. Nitric oxide is a signaling molecule in spermatozoa. Curr Pharm Des. 2003;9:419—425. [PubMed]
Hong CY, Chaput de Saintonge DM, Turner P, Fairbairn JW. Comparison of the inhibitory action of delta-9-tetrahydrocannabinol and petroleum spirit extract of herbal cannabis on human sperm motility. Hum Toxicol. 1982;1:151—154. [PubMed]
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002;54:161—202. [PubMed]
Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology. 2004;47:345—358. [PubMed]
Issidorides MR. Observations in chronic hashish users: nuclear aberrations in blood and sperm and abnormal acrosomes in spermatozoa. Adv Biosci. 1978;23:377—388.
James PS, Hennessy C, Berge T, Jones R. Compartmentalisation of the sperm plasma membrane: a FRAP, FLIP and SPFI analysis of putative diffusion barriers on the sperm head. J Cell Sci. 2004;117:6485—6495. [PubMed]
Jbilo O, Derocq JM, Segui M, Le Fur G, Casellas P. Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60. FEBS Lett. 1999;448:273—277. [PubMed]
Klegeris A, Bissonnette CJ, McGeer PL. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol. 2003;139:775—786. [PMC free article] [PubMed]
Klonoff-Cohen HS, Natarajan L, Chen RV. A prospective study of the effects of female and male marijuana use on in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) outcomes. Am J Obstet Gynecol. 2006;194:369—376. [PubMed]
Kogan NM, Mechoulam R. The chemistry of endocannabinoids. J Endocrinol Invest. 2006;29:3—14. [PubMed]
Kolodny RC, Masters WH, Kolodner RM, Toro G. Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med. 1974;290:872—874. [PubMed]
Lazzarin N, Valensise H, Bari M, Ubaldi F, Battista N, Finazzi-Agrò A, et al. Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. Gynecol Endocrinol. 2004;18:212—218. [PubMed]
Le PU, Guay G, Altschuler Y, Nabi IR. Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. J Biol Chem. 2002;277:3371—3379. [PubMed]
Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 1999;283:401—404. [PubMed]
Lewis SE, Donnelly ET, Sterling ES, Kennedy MS, Thompson W, Chakravarthy U. Nitric oxide synthase and nitrite production in human spermatozoa: evidence that endogenous nitric oxide is beneficial to sperm motility. Mol Hum Reprod. 1996;2:873—878. [PubMed]
Liu J, Batkai S, Pacher P, Harvey-White J, Wagner JA, Cravatt BF, et al. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kB independently of platelet-activating factor. J Biol Chem. 2003;278:45034—45039. [PubMed]
Logan JS, Sharma A. Potential use of genetically modified pigs as organ donors for transplantation into humans. Clin Exp Pharmacol Physiol. 1999;26:1020—1025. [PubMed]
Maccarrone M, Barboni B, Paradisi A, Bernabò N, Gasperi V, Pistilli MG, et al. Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. J Cell Sci. 2005;118:4393—4404. [PubMed]
Maccarrone M, Cecconi S, Rossi G, Battista N, Pauselli R, Finazzi-Agrò A. Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. Endocrinology. 2003;144:20—28. [PubMed]
Maccarrone M, Finazzi-Agrò A. Anandamide hydrolase: a guardian angel of human reproduction? Trends Pharmacol Sci. 2004;25:353—357. [PubMed]
Maccarrone M, Fride E, Bisogno T, Bari M, Cascio MG, Battista N, et al. Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. Mol Hum Reprod. 2004;11:21—28. [PubMed]
Mattioli M, Barboni B, Lucidi P, Seren E. Identification of capacitation in boar spermatozoa by chlortetracycline staining. Theriogenology. 1996;45:373—377. [PubMed]
Maul H, Longo M, Saade GR, Garfield RE. Nitric oxide and its role during pregnancy: from ovulation to delivery. Curr Pharm Des. 2003;9:359—380. [PubMed]
McFarland MJ, Barker EL. Lipid rafts: a nexus for endocannabinoid signaling? Life Sci. 2005;77:1640—1650. [PubMed]
Mendelson JH, Mello NK. Effects of marijuana on neuroendocrine hormones in human males and females. NIDA Res Monogr. 1984;44:97—114. [PubMed]
Mendelson JH, Mello NK, Ellingboe J. Acute effects of marihuana smoking on prolactin levels in human females. J Pharmacol Exp Ther. 1985;232:220—222. [PubMed]
Mendelson JH, Mello NK, Ellingboe J, Skupny AS, Lex BW, Griffin M. Marihuana smoking suppresses luteinizing hormone in women. J Pharmacol Exp Ther. 1986;237:862—866. [PubMed]
Montero C, Campillo NE, Goya P, Paez JA. Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study. Eur J Med Chem. 2005;40:75—83. [PubMed]
Newton SC, Murphy LL, Bartke A. In vitro effects of psychoactive and non-psychoactive cannabinoids on immature rat Sertoli cell function. Life Sci. 1993;53:1429—1437. [PubMed]
Noble K, Zhang J, Wray S. Lipid rafts, the sarcoplasmic reticulum and uterine calcium signalling: an integrated approach. J Physiol. 2007;570:29—35. [PMC free article] [PubMed]
O'Bryan MK, Schlatt S, Gerdprasert O, Phillips DJ, de Kretser DM, Hedger MP. Inducible nitric oxide synthase in the rat testis: evidence for potential roles in both normal function and inflammation-mediated infertility. Biol Reprod. 2000;63:1285—1293. [PubMed]
Oddi S, Spagnuolo P, Bari M, D'Agostino A, Maccarrone M. Differential modulation of CB1 and CB2 receptors along the neuroimmune axis. Int Rev Neurobiol. 2007;82:329—339.
Orth JM, McGuinness MP, Qiu J, Jester WF, Jr, Li LH. Use of in vitro systems to study male germ cell development in neonatal rats. Theriogenology. 1998;49:431—439. [PubMed]
Paria BC, Das SK, Dey SK. The preimplantation mouse embryo is a target for cannabinoid ligand—receptor signaling. Proc Natl Acad Sci USA. 1995;92:9460—9464.
Paria BC, Ma W, Andrenyak DM, Schmid PC, Schmid HH, Moody DE, et al. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol Reprod. 1998;58:1490—1495. [PubMed]
Paria BC, Song H, Wang X, Schmid PC, Krebsbach RJ, Schmid HH, et al. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem. 2001;276:20523—20528. [PubMed]
Park B, McPartland JM, Glass M. Cannabis, cannabinoids and reproduction. Prostaglandins Leukot Essent Fatty Acids. 2004;70:189—197. [PubMed]
Persaud TV, Ellington AC. Cannabis in early pregnancy. Lancet. 1967;2:1306.
Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med. 1998;4:1020—1024. [PubMed]
Piomelli D. THC: moderation during implantation. Nat Med. 2004;10:19—20. [PubMed]
Qazi QH, Mariano E, Milman DH, Beller E, Crombleholme W. Abnormalities in offspring associated with prenatal marihuana exposure. Dev Pharmacol Ther. 1985;8:141—148. [PubMed]
Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infection and prematurity and the role of preventive strategies. Semin Neonatol. 2002;7:259—274. [PubMed]
Rossato M, Ion Popa F, Ferigo M, Clari G, Foresta C. Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J Clin Endocrinol Metab. 2005;90:984—991. [PubMed]
Rossi G, Gasperi V, Paro R, Barsacchi D, Cecconi S, Maccarrone M. Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells. Endocrinology. 2007;148:1431—1439. [PubMed]
Sarfaraz S, Afaq F, Adhami VM, Mukhtar H. Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res. 2005;65:1635—1641. [PubMed]
Sarnataro D, Pisanti S, Santoro A, Gazzerro P, Malfitano AM, Laezza C, et al. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. Mol Pharmacol. 2006;70:1298—1306. [PubMed]
Schuel H, Burkman LJ. A tale of two cells: endocannabinoid-signaling regulates functions of neurons and sperm. Biol Reprod. 2005;73:1078—1086. [PubMed]
Schuel H, Burkman LJ, Lippes J, Crickard K, Forester E, Piomelli D, et al. N-acylethanolamines in human reproductive fluids. Chem Phys Lipids. 2002a;121:211—227. [PubMed]
Schuel H, Burkman LJ, Lippes J, Crickard K, Mahony MC, Giuffrida A, et al. Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol Reprod Dev. 2002b;63:376—387. [PubMed]
Sharkey A. Cytokines and implantation. Rev Reprod. 1998;3:52—61. [PubMed]
Sharov AA, Piao Y, Matoba R, Dudekula DB, Qian Y, VanBuren V, et al. Transcriptome analysis of mouse stem cells and early embryos. PLoS Biol. 2003;1:E74. [PMC free article] [PubMed]
Sherwood RA, Keating J, Kavvadia V, Greenough A, Peters TJ. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr. 1999;158:488—492. [PubMed]
Silver RM, Edwin SS, Trautman MS, Simmons DL, Branch DW, Dudley DJ, et al. Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide. J Clin Invest. 1995;95:725—731. [PMC free article] [PubMed]
Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31—39. [PubMed]
Szekeres-Bartho J, Faust Z, Varga P, Szereday L, Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol. 1996;35:348—351. [PubMed]
Tapanainen JS, Aittomaki K, Min J, Vaskivuo T, Huhtaniemi IT. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet. 1997;15:205—206. [PubMed]
Taylor AH, Ang C, Bell SC, Konje JC. The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum Reprod Update. 2007;13:501—513. [PubMed]
Tian X, Guo J, Yao F, Yang DP, Makriyannis A. The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer. J Biol Chem. 2005;280:29788—29795. [PubMed]
Vescovi PP, Pedrazzoni M, Michelini M, Maninetti L, Bernardelli F, Passeri M. Chronic effects of marihuana smoking on luteinizing hormone, follicle-stimulating hormone and prolactin levels in human males. Drug Alcohol Depend. 1992;30:59—63. [PubMed]
Wang H, Dey SK, Maccarrone M. Jekyll and Hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev. 2006a;27:427—448. [PubMed]
Wang H, Guo Y, Wang D, Kingsley PJ, Marnett LJ, Das SK, et al. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med. 2004;10:1074—1080. [PubMed]
Wang H, Xie H, Guo Y, Zhang H, Takahashi T, Kingsley PJ, et al. Fatty acid amide hydrolase deficiency limits early pregnancy events. J Clin Invest. 2006b;116:2122—2131. [PMC free article] [PubMed]
Wang H, Xie H, Sun X, Kingsley PJ, Marnett LJ, Cravatt BF, et al. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Prostaglandins Other Lipid Mediat. 2007;83:62—74. [PMC free article] [PubMed]
Whan LB, McClure N, Lewis SEM. The effects of tetrahydrocannabinol (THC), the primary psychoactive cannabinoid in marijuana, on in vitro human sperm motility Proceedings of the 14th Annual Symposium on the Cannabinoids (Paestum, Italy) 2004. 178p.
Whan LB, West MC, McClure N, Lewis SE. Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. Fertil Steril. 2006;85:653—660. [PubMed]
Xie XQ, Chen JZ. NMR structural comparison of the cytoplasmic juxtamembrane domains of G-protein-coupled CB1 and CB2 receptors in membrane mimetic dodecylphosphocholine micelles. J Biol Chem. 2005;280:3605—3612. [PubMed]
Yanagimachi R. Mammalian fertilization The Physiology of Reproduction 1994. Raven Press Ltd: New York; 189—196.196In: Knobil E, Neill JD (eds).
Yang ZM, Paria BC, Dey SK. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development. Biol Reprod. 1996;55:756—761. [PubMed]
Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA. 1999;96:5780—5785.
Source: CB2 receptors in reproduction
